Goldman Sachs
NVNO

Goldman Sachs’s enVVeno Medical NVNO Stock Holding History

Goldman Sachs’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-39
Closed -$127K – 5733
2018
Q2 		$127K Buy
+39
New +$151K ﹤0.01% 5144

Other funds holding NVNO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
WA
WealthTrust-Arizona Scottsdale, Arizona $172M AUM 6.58% 1-Year Est. Return

Goldman Sachs's NVNO Position: Q3 2018 in Review

Goldman Sachs sold out of enVVeno Medical (NVNO) in Q3 2018, closing a stake of 39 shares — an estimated $127K sold.

Goldman Sachs first reported a position in NVNO in Q2 2018 and held it in 1 quarter. The position peaked at $127K in Q2 2018. 3 funds tracked by Wall St. Rank hold NVNO as of Q3 2018.

  • Goldman Sachs reported no remaining enVVeno Medical position as of Q3 2018 after selling out during the quarter.
  • Goldman Sachs sold 39 enVVeno Medical shares in Q3 2018, an estimated $127K.
  • Goldman Sachs first reported a position in enVVeno Medical in Q2 2018 and held it in 1 quarter.
  • Goldman Sachs's enVVeno Medical position peaked at $127K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2018.

Based on Goldman Sachs's 13F filing for Q3 2018, filed 14 Nov 2018.